Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

USA - NASDAQ:DORM - US2582781009 - Common Stock

155.25 USD
+1.23 (+0.8%)
Last: 10/23/2025, 8:00:01 PM
155.25 USD
0 (0%)
After Hours: 10/23/2025, 8:00:01 PM
Fundamental Rating

7

DORM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 83 industry peers in the Automobile Components industry. DORM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DORM is not valued too expensively and it also shows a decent growth rate. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
In the past 5 years DORM has always been profitable.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

DORM has a better Return On Assets (9.14%) than 95.18% of its industry peers.
Looking at the Return On Equity, with a value of 16.14%, DORM belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
With an excellent Return On Invested Capital value of 12.70%, DORM belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
DORM had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 8.52%.
The 3 year average ROIC (9.34%) for DORM is below the current ROIC(12.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROIC 12.7%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 10.83%, DORM belongs to the top of the industry, outperforming 97.59% of the companies in the same industry.
In the last couple of years the Profit Margin of DORM has grown nicely.
DORM's Operating Margin of 15.75% is amongst the best of the industry. DORM outperforms 98.80% of its industry peers.
DORM's Operating Margin has improved in the last couple of years.
DORM's Gross Margin of 40.88% is amongst the best of the industry. DORM outperforms 92.77% of its industry peers.
DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DORM has less shares outstanding than it did 1 year ago.
DORM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 5.08. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
DORM's Altman-Z score of 5.08 is amongst the best of the industry. DORM outperforms 85.54% of its industry peers.
DORM has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as DORM would need 3.31 years to pay back of all of its debts.
DORM's Debt to FCF ratio of 3.31 is amongst the best of the industry. DORM outperforms 91.57% of its industry peers.
DORM has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, DORM belongs to the top of the industry, outperforming 80.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Altman-Z 5.08
ROIC/WACC1.4
WACC9.08%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.74 indicates that DORM has no problem at all paying its short term obligations.
DORM has a Current ratio of 2.74. This is amongst the best in the industry. DORM outperforms 85.54% of its industry peers.
DORM has a Quick Ratio of 1.21. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
DORM has a better Quick ratio (1.21) than 72.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 1.21
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.49%, which is quite impressive.
Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.83% on average per year.
Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 6.76% in the last year.
Measured over the past years, DORM shows a quite strong growth in Revenue. The Revenue has been growing by 15.18% on average per year.
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%

3.2 Future

DORM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.80% yearly.
Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 6.18% on average per year.
EPS Next Y25.1%
EPS Next 2Y16.16%
EPS Next 3Y14.11%
EPS Next 5Y7.8%
Revenue Next Year8.63%
Revenue Next 2Y6.76%
Revenue Next 3Y6.21%
Revenue Next 5Y6.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.84 indicates a rather expensive valuation of DORM.
DORM's Price/Earnings is on the same level as the industry average.
DORM is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.11, DORM is valued correctly.
DORM's Price/Forward Earnings ratio is in line with the industry average.
DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.33.
Industry RankSector Rank
PE 18.84
Fwd PE 16.11
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DORM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DORM is more expensive than 67.47% of the companies in the same industry.
DORM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.02
EV/EBITDA 13.27
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DORM has an outstanding profitability rating, which may justify a higher PE ratio.
DORM's earnings are expected to grow with 14.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)0.86
EPS Next 2Y16.16%
EPS Next 3Y14.11%

0

5. Dividend

5.1 Amount

DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (10/23/2025, 8:00:01 PM)

After market: 155.25 0 (0%)

155.25

+1.23 (+0.8%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners86.2%
Inst Owner Change0.03%
Ins Owners10.79%
Ins Owner Change0.28%
Market Cap4.74B
Revenue(TTM)2.09B
Net Income(TTM)225.98M
Analysts82.86
Price Target169.03 (8.88%)
Short Float %3.13%
Short Ratio4.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.85%
Min EPS beat(2)11.58%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)20.79%
Min EPS beat(4)9.67%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)21.58%
EPS beat(12)7
Avg EPS beat(12)9.41%
EPS beat(16)8
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.34%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)0.63%
PT rev (1m)1.46%
PT rev (3m)13.7%
EPS NQ rev (1m)-2.22%
EPS NQ rev (3m)31.58%
EPS NY rev (1m)3.2%
EPS NY rev (3m)12.2%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)5.98%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE 18.84
Fwd PE 16.11
P/S 2.27
P/FCF 34.02
P/OCF 27.01
P/B 3.39
P/tB 6.89
EV/EBITDA 13.27
EPS(TTM)8.24
EY5.31%
EPS(NY)9.63
Fwd EY6.21%
FCF(TTM)4.56
FCFY2.94%
OCF(TTM)5.75
OCFY3.7%
SpS68.33
BVpS45.85
TBVpS22.52
PEG (NY)0.75
PEG (5Y)0.86
Graham Number92.2
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROCE 16.84%
ROIC 12.7%
ROICexc 13.08%
ROICexgc 20.96%
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
FCFM 6.68%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Debt/EBITDA 1.12
Cap/Depr 64.28%
Cap/Sales 1.73%
Interest Coverage 10.99
Cash Conversion 45.61%
Profit Quality 61.66%
Current Ratio 2.74
Quick Ratio 1.21
Altman-Z 5.08
F-Score7
WACC9.08%
ROIC/WACC1.4
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
EPS Next Y25.1%
EPS Next 2Y16.16%
EPS Next 3Y14.11%
EPS Next 5Y7.8%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%
Revenue Next Year8.63%
Revenue Next 2Y6.76%
Revenue Next 3Y6.21%
Revenue Next 5Y6.18%
EBIT growth 1Y22.22%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year34.96%
EBIT Next 3Y9.66%
EBIT Next 5YN/A
FCF growth 1Y167.44%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y80.56%
OCF growth 3Y32.07%
OCF growth 5Y19.38%